New York City Economic Development Corporation (NYCEDC) today announced the sale of a 51,000 square foot parcel in East Harlem for the construction of The New York Proton Center (NYPC), the first proton beam therapy facility in New York State.
The Center will provide a state-of-the-art cancer treatment regimen using targeted radiation that is especially effective on pediatric, head and neck, and eye cancers, among others. Operated by a consortium of some of New York’s preeminent healthcare institutions—Memorial Sloan Kettering Cancer Center, Mount Sinai Health System, Montefiore Health System, and ProHEALTH Medical Management, LLC—and developed by Murphy & McManus, a real estate developer focused in the healthcare and life sciences sector, the new Center will revitalize an underutilized City property to strengthen New York City’s position as a global capital for cutting edge medical care and promote the continued growth of the vital bioscience and healthcare sectors.
“New York City is a global leader in the life sciences and medical care, and the new Proton Center will expand upon that status by complimenting the City’s tremendous research, development, academic and healthcare assets,” said NYCEDC Interim President Kim Vaccari. “Bringing the latest care practices to New York City is both vital to the overall economy and vital to our society, because creating jobs and having a healthy, safe and stable workforce is vital for a sustainable and equitable City.”
“The New York Proton Center members are delighted to be working with the City in developing this important healthcare project,” said NYPC spokesperson Norton Travis. “Through our collaborative efforts, we will help to revitalize and create jobs for the East Harlem community, as well as provide a cutting edge technology to further our goal of providing the most advanced clinical care.”
Support Harlem World MagazineToday!
“The New York Proton Center will offer an important healthcare option for New Yorkers, while providing local jobs to the El Barrio/East Harlem community,” said New York City Council Speaker Melissa Mark-Viverito. “The healthcare institutions and the developer have put forward a strategy to train and hire locally for a range of positions and we look forward to working with them in the months and years to come to realize their commitment to local hiring. I thank the city’s Economic Development Corporation and all those involved in bringing this innovative project to the community.” “The development of the New York Proton Center is an excellent example of how local healthcare institutions and city agencies like NYCEDC can come together to promote economic growth while bringing essential services to under-served areas,” said New York State Assembly Member Robert Rodriguez. “This is an exciting opportunity which will enhance New York City’s ability to treat the most challenging cancers, while also creating an array of healthcare jobs for residents in this community.”
NYPC, located at 225 East 126th Street in Manhattan, is expected to catalyze the growth of East Harlem. Construction is now underway, and NYPC expects to treat its first patients in the Spring of 2018 . In an effort to promote quality jobs for New Yorkers, the consortium has committed to utilizing the City’s HireNYC program for non-clinical and contract services employees and will implement robust training, internship and mentoring programs designed to improve access to quality jobs in the healthcare sector.
The healthcare sector is the leading employer in New York City, providing approximately 515,500 jobs, and has experienced exceptional growth, having created approximately 18,500 jobs over the last year. This announcement builds upon New York City’s status as a world leader for biomedical research and clinical care, with academic medical centers that have been home to some of the world’s most significant advances in medicine. The project follows the March announcement of the Early-Stage Life Sciences Funding Initiative, a $150 Million public-private partnership to identify and invest in the most promising research generated by the City’s academic medical institutions and leading entrepreneurs, creating and growing companies working on the leading edge of life sciences advances. This initiative complements the City’s suite of Healthcare and Bioscience programs, which include Pilot Health Tech NYC, a program that partners early-stage health and healthcare technology companies with key New York City healthcare service organizations and stakeholders, and incubator spaces including Harlem Biospace, a biotech incubator that provides early-stage life science companies access to affordable wet lab, microbench space, specialized laboratory equipment, mentorship, business support, and programming.
Find us on Facebook or follow us on Twitter, or visit our blogto learn more about NYCEDC projects and initiatives (source).